Blocking TGF-β in the microenvironment stimulates upregulation of TNFα and IFNγ in N1 neutrophils and causes CXCL2, CXCL5, and CCL3 production that leads to further recruitment of neutrophils to the tumor site (79). The gene discussed is TGFB1; the disease is neoplasm.